Dingpei Han
Papers
14
Total Citations
253
H-Index
5
About
Dingpei Han is a thoracic surgeon and clinical researcher whose work has significantly advanced the understanding and adoption of robotic-assisted thoracic surgery (RATS) for lung cancer and mediastinal disease. His research sits at the intersection of minimally invasive surgical innovation and oncological outcomes, with a particular focus on comparing robotic-assisted lobectomy (RAL) with video-assisted thoracoscopic surgery (VAL) in patients with non-small-cell lung cancer (NSCLC). Han's most influential contribution — a 2021 comparative study on RAL versus VAL that has garnered 116 citations — helped establish the perioperative and long-term efficacy profile of robotic approaches in NSCLC treatment. This was complemented by his landmark 2024 randomized controlled trial, the RVlob study, which provided the field's first high-quality prospective evidence on this comparison. His 2020 single-institution series on robotic resection of mediastinal masses (72 citations) further demonstrated the feasibility and safety of RATS across diverse thoracic pathologies. Beyond lobectomy, Han has pioneered robotic combined anatomic subsegmentectomy for early-stage lung cancer, reflecting his commitment to precision, parenchyma-sparing surgery. Through a prolific body of technical reports and cohort studies, Han has helped standardize robotic thoracic procedures, making him a notable voice in the evolution of minimally invasive thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1Robotic-assisted Versus Video-assisted Thoracoscopic Lobectomy116 citations · 2021
- 2
- 3
- 4
- 5
- 6Robotic-assisted right middle lobectomy4 citations · 2017
- 7Robot-assisted surgery for posterior superior mediastinal mass3 citations · 2017
- 8Robotic-assisted thoracoscopic surgery: left upper lobectomy3 citations · 2017
- 9
- 10Robotic-assisted thoracoscopic surgery: right inferior lobectomy2 citations · 2017